Durvalumab in DLBCL After Autologous Transplant
Clinical trial NCT03241017 · WITHDRAWN
Trial details
- NCT number
- NCT03241017
- Sponsor
- Insel Gruppe AG, University Hospital Bern
- Status
- WITHDRAWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-10-01
- Primary completion
- 2021-10-01
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.